首页> 外国专利> TREATMENT OF ACUTE HEADACHES AND CHRONIC PAIN USING RAPIDLY-CLEARED ANESTHETIC DRUG AT SUB-ANESTHETIC DOSAGES

TREATMENT OF ACUTE HEADACHES AND CHRONIC PAIN USING RAPIDLY-CLEARED ANESTHETIC DRUG AT SUB-ANESTHETIC DOSAGES

机译:亚麻醉剂量的快速清除麻醉药治疗急性头痛和慢性疼痛

摘要

A rapidly-cleared anesthetic drug such as propofol can be used to treat migraine or cluster headaches and other 'runaway pain' conditions. When used at a sub-anesthetic dosage level that does not cause a loss of consciousness, propofol (a drug used in surgical anesthesia, which is normally injected but which also can be inhaled) induces a feeling of sedated relaxation. This sedated relaxed condition can interrupt and stop a 'runaway pain' condition such as a migraine or cluster headache, as well as various types of intractable chronic pain, such as trigeminal facial pain or arachnoiditis. Typical treatments have used about 2 to 3 ml initially, followed by additional 2-3 ml boluses at timed intervals, depending on the pain status reported by the patient. When a desired level of sedation is reached and the patient reports that the pain is gone, the drug is terminated. It should be rapidly metabolized and eliminated from the blood, so that patients can recover quickly to an alert and functioning state (usually within 10 to 15 minutes, when propofol is used) and can safely drive away from a clinic and return to work or other normal activities, with no unpleasant side-effects or lingering after-effects. In tests on patients suffering acute migraine or cluster headaches or early-onset symptoms of cluster headache, most patients reported 100% relief with no problems of rebound headache the following day. In patients treated for chronic intractable pain, propofol treatment usually provided effective pain relief for about 3 to 5 days before another treatment was needed.
机译:快速清除的麻醉药(如丙泊酚)可用于治疗偏头痛或丛集性头痛以及其他“失控的疼痛”状况。当以不会引起意识丧失的亚麻醉剂量使用时,丙泊酚(一种用于手术麻醉的药物,通常可以注射但也可以吸入)会引起镇静放松的感觉。这种镇静的放松状态可以中断并停止“偏头痛”状态,例如偏头痛或丛集性头痛,以及各种类型的顽固性慢性疼痛,例如三叉神经性面部疼痛或蛛网膜炎。典型的治疗方法最初是使用约2到3毫升,然后根据患者报告的疼痛状况,在一定的间隔内再使用2-3毫升大剂量。当达到所需的镇静水平并且患者报告疼痛消失时,药物将终止。它应迅速代谢并从血液中清除掉,以便患者可以迅速恢复到机敏和功能正常的状态(通常在使用丙泊酚的情况下,在10到15分钟之内),并可以安全地离开诊所回到工作场所或其他地方正常活动,没有不良的副作用或后遗症。在对患有急性偏头痛或丛集性头痛或早期发作的丛集性头痛症状的患者进行的测试中,大多数患者第二天报告的缓解率均为100%,而没有反弹性头痛的问题。对于患有慢性顽固性疼痛的患者,丙泊酚治疗通常可在需要另一种治疗之前有效缓解疼痛约3-5天。

著录项

  • 公开/公告号EP1124416A1

    专利类型

  • 公开/公告日2001-08-22

    原文格式PDF

  • 申请/专利权人 KRUSZ JOHN CLAUDE;

    申请/专利号EP20000918120

  • 发明设计人 KRUSZ JOHN CLAUDE;

    申请日2000-03-15

  • 分类号A01N31/08;A01N37/12;A01N37/44;A61K31/05;C07C39/06;

  • 国家 EP

  • 入库时间 2022-08-22 01:15:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号